Search

Your search keyword '"Lafayette, Richard"' showing total 583 results

Search Constraints

Start Over You searched for: Author "Lafayette, Richard" Remove constraint Author: "Lafayette, Richard"
583 results on '"Lafayette, Richard"'

Search Results

1. Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study

2. Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome

3. Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy

4. Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy: Randomized, Double-Blind Clinical Trial

5. Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial

8. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

11. A Focus Group Study of Self-Management in Patients With Glomerular Disease

13. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

15. The Significance of Hematuria in Podocytopathies

17. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

18. Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy

21. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network

22. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

24. Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease

25. Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

26. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

27. Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy

28. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.

31. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

32. The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

34. #812 Phase 2b ORIGIN study open label extension with atacicept in patients with IgA nephropathy and persistent proteinuria: week 72 interim analysis

36. #1021 A phase 3 randomized controlled trial of ravulizumab in adult patients with IgA nephropathy

37. #145 Subgroup and secondary endpoint evaluation of a phase 2 randomized placebo-controlled trial of ravulizumab in IgA nephropathy

38. #425 Felzartamab (anti-CD38) in patients with IgA Nephropathy—interim results from the IGNAZ study

39. #123 Impact of atacicept on hematuria in IGA nephropathy: post-hoc analysis of the phase 2b ORIGIN study

40. Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease

41. Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network

42. Preparation and Rationale for a Patient-Centered Clinical Outcome Assessment Set of Fluid Overload for Drug Development in Nephrotic Syndrome

43. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis

47. Persistent Disease Activity in Patients With Long-Standing Glomerular Disease

50. WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN

Catalog

Books, media, physical & digital resources